期刊文献+

多巴胺和去甲肾上腺素治疗感染性休克的研究进展 被引量:9

Research Progress on the Effect of Dopamine and Norepinephrine in Treating Sepsis Shock
下载PDF
导出
摘要 感染性休克是感染所致的血流动力学异常,早期血流动力学表现为高排低阻,从而导致外周组织灌注不足及缺氧,如果不能及时逆转,最终导致多器官功能衰竭。感染性休克病死率极高,严重威胁着人类健康。多巴胺与去甲肾上腺均为治疗感染性休克的一线药物。最新研究证实,多巴胺较去甲肾上腺素不良反应更明显,而传统观点认为具有肾脏毒性的去甲肾上腺素不仅具有更好的有效率,而且其对于肾脏、胃肠道、心血管系统、呼吸系统的不良影响并不比多巴胺大。 Septic shock is a kind of abnormal hemodynamics caused by infection,whose early manifestation is high discharge and low resistance,resulting in peripheral tissue hypoperfusion and hypoxia.If not be reversed in time,it will lead to multiple organ failures eventually.The mortality rate of septic shock is extremely high,that it seriously threatens the human health.Dopamine and norepinephrine can both be used as the first-line drugs for septic shock.Recent research indicates the side-effect of dopamine is more obvious than norepinephrine,while the conventional theory indicates norepinephrine could have better effect and less side-effect on kidney,gastrointestinal tract,cardiovascular system,respiratory system than dopamine,despite of its toxicity to kidney.
出处 《医学综述》 2014年第19期3499-3500,共2页 Medical Recapitulate
关键词 感染性休克 多巴胺 去甲肾上腺素 Septic shock Dopamine Norepinephrin
  • 相关文献

参考文献22

  • 1Kampmeier TG,Rehberg S,Westphal M,et al.Vasopressin in sepsis and septic shock[J].Minerva Anestesiol,2010,76(10):844-850.
  • 2Guérin JP,Levraut J,Samat-Long C,et al.Effects of dopamine and norepinephrine on systemic and hepatosplanchnic hemodynamics,oxygen exchange and energy balance in vasoplegic septic patients[J].Shock,2005,23(1):18-24.
  • 3Kellum JA,Decker J.Use of dopamine in acute renal failure:ameta-analysis[J].Crit Care Med,2001,29(8):1526-16531.
  • 4高言国,张彧.不同血管活性药对脓毒性休克患者血流动力学和乳酸清除率的作用[J].医学综述,2009,15(11):1759-1760. 被引量:7
  • 5Sakr Y,Reinhart K,Vincent JL,et al.Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrencein Acutely Ill Patients(SOAP) Study[J].Crit Care Med,2006,34(3):589-597.
  • 6Martin C,Viviand X,Leone M,et al.Effect of norepinephrine on the outcome of septic shock[J].Crit Care Med,2000,28(8):2758-2765.
  • 7Patel GP,Grahe JS,Sperry M,et al.Efficacy and safety of dopamine versus norepinephrine in the management of septic shock[J].Shock,2010,33(4):375-380.
  • 8Boulain T,Runge I,Bercault N,et al.Dopamine therapy in septicshock:detrimental effect on survival?[J].J Crit Care,2009,24(4):575-582.
  • 9H amzaoui O,Georger JF,Monnet X,et al.Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threaten ing hypotension[J].Crit Care,2010,14(4):R142.
  • 10高景利,李晓岚,王爱田.比较多巴胺与去甲肾上腺素对感染性休克血流动力学和氧代谢的影响[J].疑难病杂志,2008,7(7):390-393. 被引量:10

二级参考文献22

  • 1邱海波,杨毅,刘松桥.《2004严重感染和感染性休克治疗指南》系列讲座(2) 严重感染和感染性休克的容量复苏和血管活性药物应用[J].中国危重病急救医学,2004,16(8):451-453. 被引量:111
  • 2侯立朝,计根林,熊利泽,陈绍洋,陈敏,霍婷婷,胡文能,王雅丽,汪晨,白晓光.多巴胺联合去甲肾上腺素对感染性休克患者肾脏功能的影响[J].中华外科杂志,2006,44(17):1206-1208. 被引量:13
  • 3苏群,方强,吴立峰,严静.液体复苏对严重脓毒症及脓毒性休克患者的治疗作用研究[J].中华外科杂志,2006,44(19):1336-1338. 被引量:17
  • 4LevyM M,FinkM P,Marshall JC,et al.2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference[J].Crit Care Med,2003,31(4):1250-1256.
  • 5Roman MO,Orellana JC,Debacker D,et al.Septic shock of early or lateonset:dose it matter?[J].Chest,2004,126(1):173-178.
  • 6Martin C,Viviand X,Leone M,et al.Effect of norepinephrine on the outCome of septic shock[J].Crit Care Med,2000,28(8):2758-2765.
  • 7Nguyen HB,Corbett SW,Steele R,et al.Implementation of a bundle of QUALITY indicators for the ealy management of severe sepisi and septic shock is associated with decrased mortality[J].Crit Care Med,2007,35(4):1105-1112.
  • 8Nguyen HB,Rivers EP,Knoblich BP,et al.Early lactate clearance is associated with improved outcome in severe sepsis and septic shock[J].Crit Care Med,2004,32(8):1637-1642.
  • 9Sakr Y,Reinhart K,Vincent JL,et al.Dose dapomine administration in Shock influence outcome? Results of the sepis occurrence inacutely ill patients(SOAP) study[J].Crit Care Med,2006,34(3):589-597.
  • 10Chamorro C,Romera MA,Martinez Melgar JL,et al.Dopamine dose and renal damage[J].Lancet,2001,357(9269):1707-1708.

共引文献24

同被引文献82

  • 1蒙瑞,刘云霞.多巴胺受体激动剂的药理研究进展[J].求医问药(下半月),2013(1):357-357. 被引量:3
  • 2Mitchell M. Levy,R Phillip Dellinger,Sean R. Townsend,Walter T. Linde-Zwirble,John C. Marshall,Julian Bion,Christa Schorr,Antonio Artigas,Graham Ramsay,Richard Beale,Margaret M. Parker,Herwig Gerlach,Konrad Reinhart,Eliezer Silva,Maurene Harvey,Susan Regan,Derek C. Angus.The Surviving Sepsis Campaign: Results of an international guideline-based performance improvement program targeting severe sepsis[J].Critical Care Medicine.2010(2)
  • 3杜婷婷,廖为民.参附注射液在心肺复苏中的研究进展[C].江西省第8次中西医结合危重病、急救医学学术研讨会论文集,2013:39-42.
  • 4王明强.血必净联合参附注射液对感染性休克患者血流动力学及炎性因子的影响[J].中华急诊医学杂志,2014,11(1):112-116.
  • 5James A. Russell,Keith R. Walley.Vasopressin and Its Immune Effects in Septic Shock. JOURNAL OF INNATE IMMUNITY . 2010
  • 6Naved Saad Ahmed,Siddiqui Shahla,Khan Fazal Hameed.APACHE-II score correlation with mortality and length of stay in an intensive care unit. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP . 2011
  • 7Pepper DJ,Sun J,Welsh J,et al.Increased body mass index and adjusted mortality in ICU patients with sepsis or septic shock:a systematic review and meta-analysis[J].Crit Care,2016,20(1):181.DOI:10.1186A13054-016-1360-z.
  • 8Goto T.Yoshida K.Tsugawa Y,et al.Mortality trends in U.S.adults with septic shock,2005-2011:a serial cross-sectional analysis of nationally-representative data[J].BMC Infect Dis,2016,16(1):294.DOI:10.1186/s12879-016-1620-l.
  • 9Rello J,Valenzuela-Sanchez F.Septic shock in the era of precision medicine[J].J Thorac Dis,2016,8(6):1022-1023.DOI:10.21037/jtd.2016.03.83.
  • 10Choe EA,Shin TG,Jo IJ.et al.The prevalence and clinical significance of low procalcitonin levels among patients with severe sepsis or septic shock in the emergency department[J].Shock,2016,46(1):37-43.

引证文献9

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部